Citius Pharmaceuticals, Inc. (CTXR)
NasdaqCM - NasdaqCM Real Time Price. Currency in USD
Add to watchlist
At close: 04:00PM EST
After hours:
| Previous Close | 1.3900 |
| Open | 1.4000 |
| Bid | 1.3800 x 1200 |
| Ask | 1.4500 x 3100 |
| Day's Range | 1.3500 - 1.4500 |
| 52 Week Range | 0.7700 - 2.0100 |
| Volume | |
| Avg. Volume | 758,966 |
| Market Cap | 206.158M |
| Beta (5Y Monthly) | 1.20 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -0.2020 |
| Earnings Date | Feb 08, 2023 - Feb 13, 2023 |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 7.00 |
- ACCESSWIRE
Sidoti's January Micro-Cap Conference
Sidoti & Company, LLC has released the presentation schedule and weblinks for its two-day January Micro-Cap Conference taking place Wednesday and Thursday, January 18-19, 2023.
- Simply Wall St.
Here's Why We're Not Too Worried About Citius Pharmaceuticals' (NASDAQ:CTXR) Cash Burn Situation
There's no doubt that money can be made by owning shares of unprofitable businesses. For example, although...
- Zacks
After Plunging -30.6% in 4 Weeks, Here's Why the Trend Might Reverse for Citius Pharmaceuticals, Inc. (CTXR)
The heavy selling pressure might have exhausted for Citius Pharmaceuticals, Inc. (CTXR) as it is technically in oversold territory now. In addition to this technical measure, strong agreement among Wall Street analysts in revising earnings estimates higher indicates that the stock is ripe for a trend reversal.
© 2023 Yahoo. All rights reserved.
